the Semax Semax is approved by the Ministry of Health of the Russian Federation as a nootropic and neuroprotective drug
Enhanced (NYSE: ENHA) is an elite sports competition and performance products company committed to giving athletes and people alike access to products and protocols that optimize health, performance, and recovery, through its Enhanced Games, Enhanced Breakers series events and its Live Enhanced consumer telehealth platform
Compounding pharmacies in the United States previously prepared BPC-157 for clinical use, but the FDA issued guidance restricting its inclusion in compounded preparations due to its lack of an approved new drug application (NDA)
They are not intended for human, veterinary, or therapeutic use
Cost-efficiency: Long-term, at-home injections can be more budget friendly than repeat clinic visits
DSIP is one of the earliest neuropeptides to enter the sleep-research literature, and it remains one of the least understood